Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

Suggestions For Future Interviews: Pivot, Pivot,

Message Board Public Reply | Private Reply | Keep | Replies (1)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 155054
(Total Views: 1078)
Posted On: 04/08/2020 4:52:05 PM
Posted By: the lawman
Suggestions For Future Interviews: Pivot, Pivot, and Pivot again.

As politicians do, any person being interviewed needs to script what he/she wants to say, and pivot from the question asked, and give such scripted answers.

In the four minutes he was interviewed by Charles Payne, Pourhassan could and should have been prepared to say, and pivoted to say:

1. 4 out of 9 seriously ill Covid-19 patients who were treated with Leronlimab at a leading New York City hospital, were able to be taken off of their ventilators after only three days.

2. The immune function in all 9 of these seriously ill Covid-19 patients was fully restored after 7 days, while their cytokine storms were reduced by between 70 and 90 percent.

3. The patients who improved greatly on Leronlimab had previously been treated, without success, on either hydroxychloride or remdesivir. In other words, these 9 patients had better results after being treated with Leronlimab than they had with either hydroxychloride or remdesivir.

4. In over 800 patients who have been treated with Leronlimab over the past five years for HIV and metastatic breast cancer, there has not been one serious adverse event attributable to this drug.

5. Leronlimab is now in two FDA approved clinical trials for mild to moderate, and seriously ill, Covid-19 patients. Cytodyn expects to have at least some results for these trials within 30 days.

If Pourhassan had made these comments, in response to whatever questions Payne offered, the viewers would have come away with a much more favorable impression of Leronlimab.

If someone knows Charles Payne, they might want to advise him of the above, so he would be able to ask questions that would be conducive to eliciting this information.

However, if the questions by Payne, or any future interviewer, are not phrased so as to elicit this information, Pourhassan must pivot, and provide this information, just as every politician pivots in responding to questions from reporters.

LM



(8)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  


The Lawmanstyle="color:red">The Lawman"color:red">The Lawman:red">The LawmanThe Lawmanspan>Lawmanawmanimg]




Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us